Behavioral Symptoms  >>  lurasidone  >>  Phase 3
Welcome,         Profile    Billing    Logout  

8 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
lurasidone / Generic mfg.
NCT00868452 / 2008-007482-23: Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)

Checkmark For depressive episodes associated with bipolar I disorder [PREVAIL-1 & PREVAIL-2]
May 2013 - May 2013: For depressive episodes associated with bipolar I disorder [PREVAIL-1 & PREVAIL-2]
Completed
3
348
US, Europe, RoW
lurasidone + (lithium or divalproex), Placebo + (lithium or divalproex)
Sunovion
Bipolar Depression
12/11
01/12
NCT00868699 / 2008-007457-13: Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Monotherapy)

Checkmark For depressive episodes associated with bipolar I disorder [PREVAIL-1 & PREVAIL-2]
May 2013 - May 2013: For depressive episodes associated with bipolar I disorder [PREVAIL-1 & PREVAIL-2]
Completed
3
505
US, Europe, RoW
lurasidone, Placebo
Sunovion
Bipolar Depression
02/12
02/12
PREVAIL3, NCT01284517 / 2010-019778-34: Lurasidone HCI - A 6-week Phase 3 Study of Patients With Bipolar I Depression

Completed
3
356
Japan, US, Canada, Europe, RoW
Lurasidone, Latuda, Placebo
Sunovion
Bipolar Depression
08/12
08/12
RESOLVE2, NCT01423240: Major Depressive Disorder With Mixed Features

Withdrawn
3
0
US
Lurasidone 20 mg, Latuda, Lurasidone 60 mg, Placebo
Sunovion
Major Depressive Disorder
12/12
12/12
NCT00868959 / 2008-007483-42: Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

Completed
3
817
Japan, US, Canada, Europe, RoW
lurasidone
Sunovion
Bipolar Depression
02/13
02/13
RESOLVE3, NCT01423253: Major Depressive Disorder With Mixed Features - Extension

Completed
3
48
US
Lurasidone, Latuda
Sunovion
Major Depressive Disorder
10/13
10/13
RESOLVE 1, NCT01421134 / 2012-004132-33: Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose

Completed
3
211
US, Europe, RoW
Lurasidone, Latuda, Placebo
Sunovion
Major Depressive Disorder With Mixed Features
10/14
10/14
Illuminate, NCT02046369 / 2013-004903-37: Lurasidone Pediatric Bipolar Study

Completed
3
350
US, Europe, RoW
Lurasidone, Latuda, Placebo
Sunovion
Bipolar I Depression
10/16
10/16

Download Options